http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108498536-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F120-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F8-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F120-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2018-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108498536-B |
titleOfInvention | The purposes of sulfated heparin disaccharides grafting polymethyl acyl ethanol amine |
abstract | The characteristics of the invention belongs to biomedical materials fields, specifically disclose a kind of purposes of sulfated heparin disaccharides grafting polymethyl acyl ethanol amine, and the sulfated heparin disaccharides grafting polymethyl acyl ethanol amine anti-tumor activity is strong, low anticoagulant active;Sulfated heparin disaccharides used in the present invention is grafted the research that polymethyl acyl ethanol amine prepares treatment anti-tumor drug for heparin and provides a new direction. |
priorityDate | 2018-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.